Asia-Pacific

Wu Xiaohui of Wanhuida Intellectual Property explains a pioneering case heard by the Intellectual Property Court of the Supreme People’s Court and considers its implications for original and generic drug makers

Ruixian Liu of Kangxin Partners considers what patentees can do to prevent claims being declared invalid because their amendments go beyond the scope of the original application

Jianhui Li of Wanhuida Intellectual Property explains how China addresses the question of whether the features of an administration process limit a patented product and distinguish it from prior art

Yue Guan of Wanhuida Intellectual Property reports on a case in China that has implications for the drafting of compound patents incorporating Markush claims

Guanyang Yao and Ran Wang of Liu, Shen & Associates weigh up the pros and cons of pursuing both civil litigation and administrative action when seeking IP protection in China

Fabio Giacopello and Daniel de Prado Escudero of HFG Law & Intellectual Property analyse how the applicability of trademarks has evolved amid the widespread use of original equipment manufacturers in China by overseas companies